The morality and ethics governing CRISPR–Cas9 patents in China

The morality and ethics governing CRISPR–Cas9 patents in China

Chinese patent law may not be equipped to deal with the potential moral issues raised by gene-editing technology.

The Ethics of Gene Editing: Navigating Humanist Values in Biotechnology

At the heart of every gene we edit lies a deeper question: What does it mean to be human?

The $100 billion genomic revolution

Hi, it’s Azeem. Here’s the thing about platform technologies that most people miss: the greatest value creation happens when seemingly distinct technologies converge into a unified ecosystem. In late 2023, the FDA approved the first CRISPR gene-editing treatment for sickle cell disease. But this isn’t just about CRISPR; it’s about the entire genomic technology stack coming of age simultaneously. Gene editing, gene therapies and sequencing are pr…